# Gastrografin for Treating Small Bowel Obstruction in Children

> **NCT03573921** · PHASE2,PHASE3 · TERMINATED · sponsor: **London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's** · enrollment: 2 (actual)

## Conditions studied

- Small Bowel Obstruction

## Interventions

- **DRUG:** Gastrografin
- **OTHER:** Saline solution (control treatment)

## Key facts

- **NCT ID:** NCT03573921
- **Lead sponsor:** London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-09-01
- **Primary completion:** 2022-12-19
- **Final completion:** 2022-12-19
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** Poor recruitment to date.
- **Last updated:** 2023-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03573921

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03573921, "Gastrografin for Treating Small Bowel Obstruction in Children". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT03573921. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*